Markets Stocks Economy Crypto Earnings Banking Energy
Home› Stocks› Feature
Stocks · Exclusive

Oppenheimer sees more Cheesecake Factory earnings upgrades ahead

Oppenheimer sees more Cheesecake Factory earnings upgrades ahead
Stocks · 2026
Photo · Marcus Devlin for Daily Digest Invest
By Marcus Devlin Equities Correspondent Oct 6, 2026 3 min read

Investment bank Oppenheimer has raised its profit forecasts for The Cheesecake Factory for 2026 and 2027, and it thinks more analysts will follow suit. In a note Tuesday, the bank said the restaurant chain's same-store sales trends look durable enough to support a longer cycle of upward earnings revisions.

Same-store sales—revenue from locations open at least a year—are a key gauge for restaurant investors because they strip out the effect of new openings and give a cleaner read on underlying demand and pricing power. When a company consistently beats on this metric, it often signals that its brand and menu are resonating with customers.

What the bank is saying

Oppenheimer modeled same-store sales growth of 9.1% for the third quarter and 7% for the fourth quarter. Those figures are above the broader Wall Street consensus of 7.6% and 4.8%, respectively. The bank's view is that the recent run-rate is not a one-off spike but a more sustainable trend, which is why it raised its earnings per share (EPS) estimates for both 2026 and 2027.

EPS is simply a company's profit divided by its shares outstanding, and it's the most common way analysts measure a company's profitability. When analysts raise EPS forecasts, it often pushes stock prices higher because investors are willing to pay more for expected future earnings.

The Cheesecake Factory, known for its extensive menu and cheesecake desserts, operates more than 300 restaurants in the U.S. and internationally. The company has been navigating higher food and labor costs, but its ability to keep sales growing at existing locations suggests it has pricing power—meaning it can raise menu prices without driving away customers.

Why this matters for investors

For everyday investors, the key takeaway is that analyst upgrades can be a self-reinforcing cycle. When one bank raises its estimates, others often follow, which can lift the stock further. Oppenheimer's note suggests that the market may be underestimating the strength of Cheesecake Factory's sales momentum.

However, it's important to remember that analyst forecasts are just educated guesses. They can be wrong, and the stock price already reflects a lot of expectations. If the company's actual results fall short of these optimistic numbers, the stock could drop.

Investors should also consider the broader restaurant industry context. Many casual dining chains have struggled to grow sales as consumers become more price-sensitive. Cheesecake Factory's apparent resilience could be a positive signal for the sector, but it's not guaranteed to last.

What to watch next

The company is expected to report its third-quarter earnings in the coming weeks. That report will be the first real test of whether the sales trends Oppenheimer highlights are actually materializing. If the company beats expectations and raises its own guidance, it could validate the bank's upgrade cycle thesis. If it disappoints, the opposite could happen.

Investors might also keep an eye on broader market conditions. For example, Treasury yields easing can affect how investors value growth stocks, including restaurant chains. Similarly, global market moves can influence sentiment, though Cheesecake Factory's business is largely domestic.

In the meantime, the stock's performance will likely hinge on whether other analysts join Oppenheimer in raising their numbers. A wave of upgrades could push the shares higher, but it also raises the bar for the company's actual results.

For those who own the stock, the message is to stay informed but not overreact to a single analyst note. For those considering a purchase, it's worth remembering that past sales trends don't guarantee future results. As always, diversification and a long-term perspective remain the best defenses against uncertainty.

More from this story

Next article · Don't miss

McKesson and CD&R to buy Option Care Health for $5.8 billion

McKesson and private equity firm CD&R will buy Option Care Health for $32.05 per share, a deal worth about $5.8 billion. The acquisition underscores the growing appeal of home-based healthcare services.

Read the story →
McKesson and CD&R to buy Option Care Health for $5.8 billion